Generic

Itra 200 Tablet contains the active ingredient Itraconazole 200mg, an antifungal medication by Square Pharmaceuticals Limited, targeting a range of fungal infections.

Description

Itra 200, containing Itraconazole, is an antifungal treatment primarily designed to treat various fungal infections such as candidiasis and aspergillosis. Utilizing Super Bio-available (SUBA) technology, Itra 200 ensures enhanced absorption, providing efficient treatment for both systemic and localized fungal infections.

Benefits

• Provides relief from a wide range of fungal infections, including skin, nail, and systemic infections.
• Uses SUBA technology to improve bioavailability and efficacy.
• Suitable for long-term maintenance therapy in immunocompromised patients.
• Prescribed for preventive treatment in high-risk patients during neutropenia.

Ingredients

Active Ingredient: Itraconazole 200mg. Inactive ingredients may include binders, fillers, and polymers specific to Square Pharmaceuticals’ formulation.

Uses and Doses

• Non-Systemic Infections: 200 mg once daily for conditions like vulvovaginal candidiasis and tinea versicolor.
• Systemic Infections: Dose varies, generally starting at 200 mg once or twice daily, with adjustments based on infection severity and patient response.
• Special Cases: Maintenance in AIDS patients and prophylactic use during neutropenia.

Side Effects

Possible side effects include nausea, abdominal pain, constipation, headache, dizziness, menstrual disorders, liver enzyme elevation, allergic reactions, peripheral neuropathy, and rare cases of Stevens-Johnson syndrome. Prolonged use may lead to hypokalemia, edema, and hair loss.

How to Use

Take Itra 200 after a full meal to improve absorption. For acid-reducing medications, administer them at least 2 hours after Itra 200. Always follow the prescribed duration and dosage.

Pregnancy & Lactation

Itraconazole is contraindicated during pregnancy and breastfeeding, as it poses risks to fetal and infant health.

Precautions and Warnings

Itra 200 absorption is impaired when gastric acidity is reduced; antacids should be taken two hours post-dose. Regular monitoring of liver function is advised for patients on extended treatments. Avoid Itraconazole in cases of hypersensitivity or severe liver disease.

Safety Information

Consult a healthcare provider before starting Itra 200. Avoid concurrent use with certain drugs like terfenadine, cisapride, and simvastatin. Store below 25°C, away from light and moisture, and keep out of reach of children.

Indications

Itra 200 is indicated for treating oropharyngeal and vulvovaginal candidiasis, pityriasis versicolor, tinea infections, onychomycosis, histoplasmosis, systemic candidiasis, aspergillosis, cryptococcosis, and for maintenance in AIDS patients.

Pharmacology

Itraconazole inhibits Cytochrome P-450 enzymes, which disrupt ergosterol synthesis in fungal cell membranes. This results in impaired membrane function, abnormal cell wall formation, and inhibition of fungal growth.

Therapeutic Class

Itra 200 belongs to the therapeutic class of drugs used to treat subcutaneous and systemic mycoses.

Storage Conditions

Store below 25°C in a cool, dry place, protected from light. Keep out of children’s reach.

3 FAQ

1. What is Itra 200 used for? Itra 200 is prescribed to treat fungal infections like candidiasis, aspergillosis, and systemic fungal diseases.
2. Can I take Itra 200 during pregnancy? No, Itra 200 is not recommended for use during pregnancy or breastfeeding due to potential risks.
3. How should I take Itra 200? Take Itra 200 after a full meal, and consult your healthcare provider for the correct dosage and duration.

Disclaimer

This information is not a substitute for medical advice. Please consult your healthcare provider to determine the appropriate usage and dosage for your specific condition.

Keywords: Itraconazole, antifungal, Itra 200, Square Pharmaceuticals, candidiasis treatment, aspergillosis, tinea infections, fungal infection, systemic candidiasis, oral medication, anti-fungal drug, SUBA technology, immunocompromised therapy, onychomycosis, cryptococcosis, bioavailability, fungal cell membrane, medication for fungal diseases, antifungal therapy, Itra tablet.